Home of the epic podcast where three awesome friends get together along with an occasional guest to rant and rave about random topics surrounding movies, TV shows, videos games and life in general for your entertainment!
…
continue reading
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
…
continue reading
Vivek Reddy and C. Michael Gibson compare pulsed field ablation versus thermal ablation for patients with paroxysmal atrial fibrillation.By TCTMD
…
continue reading
Mathieu Kerneis and C. Michael Gibson compare outcomes of patients treated with anakinra, a new therapy for acute myocarditis, or placebo.By TCTMD
…
continue reading
Dan Jones and C. Michael Gibson discuss whether inorganic nitrate reduces contrast-induced nephropathy after angiography in ACS patients.By TCTMD
…
continue reading
Zachary Cox and C. Michael Gibson discuss whether early dapagliflozin initiation is safe and effective for patients with acute heart failure.By TCTMD
…
continue reading
Shaoping Nie, Gilles Montalescot, and C. Michael Gibson discuss prolonged anticoagulation after primary PCI for patients with MI.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Four-Year Results: The EVOLUT Low Risk Trial
5:51
5:51
Play later
Play later
Lists
Like
Liked
5:51
Michael J. Reardon and C. Michael Gibson discuss the trial's 4-year results in low-surgical-risk patients with severe aortic stenosis randomized to self-expanding TAVI or SAVR.By TCTMD
…
continue reading
Robert W. Yeh and C. Michael Gibson discuss the primary outcomes of this eagerly awaited trial comparing the AGENT paclitaxel-coated balloon with conventional balloon angioplasty for in-stent restenosis.By TCTMD
…
continue reading
Susheel K. Kodali and C. Michael Gibson discuss transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation.By TCTMD
…
continue reading
Josep Rodés-Cabau and C. Michael Gibson discuss the benefits of TAVI versus SAVR in patients with severe aortic stenosis and small aortic annuli.By TCTMD
…
continue reading
A. Michael Lincoff and C. Michael Gibson discuss the cardiovascular impact of semaglutide in patients with overweight or obesity but without diabetes.By TCTMD
…
continue reading
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.By TCTMD
…
continue reading
Christopher Rajkumar, Rasha Al-Lamee, and C. Michael Gibson discuss this randomized trial of PCI versus a placebo procedure for stable angina.By TCTMD
…
continue reading
Mandeep Mehra and C. Michael Gibson discuss whether or not aspirin is needed for patients with left ventricular assist devices in advanced heart failure.By TCTMD
…
continue reading
Christian T. Ruff and C. Michael Gibson discuss the primary results of a randomized trial testing the efficacy of abelacimab versus rivaroxaban for stroke prevention in atrial fibrillation.By TCTMD
…
continue reading
Andrew Bellinger, Sek Kathiresan, and C. Michael Gibson talk about the phase 1b trial of what investigators hope may be a one-time genetic fix for hyperlipidemia.By TCTMD
…
continue reading
Steven Nissen and C. Michael Gibson discuss the efficacy and safety of lepodisiran, an extended duration short-interfering RNA meant to reduce lipoprotein (a).By TCTMD
…
continue reading
Paul Ridker and C. Michael Gibson discuss whether residual inflammatory risk or residual cholesterol risk is a more effective predictor of CV events among patients treated with statins.By TCTMD
…
continue reading
Mike Sharma and C. Michael Gibson discuss managing acute thromboembolic events in secondary stroke using antithrombotic treatment with factor XIa inhibition.By TCTMD
…
continue reading
Axel Bauer and C. Michael Gibson talk about whether smartphone-based screening can effectively detect atrial fibrillation in elderly, at-risk patients.By TCTMD
…
continue reading
Ganesan Karthikeyan and C. Michael Gibson compare the efficacy of rivaroxaban versus vitamin K agonists for patients with rheumatic heart disease associated atrial fibrillationBy TCTMD
…
continue reading
Joo-Yong Hahn and C. Michael Gibson compare FFR with angiography-guided PCI for patients with acute myocardial infarction and multivessel disease.By TCTMD
…
continue reading
Marco Valgimigli and C. Michael Gibson discuss the long-term follow-up results from MASTER DAPT, which compared the outcomes of high bleeding risk patients randomized to either abbreviated or standard antiplatelet therapy.By TCTMD
…
continue reading
Marco Valgimigli and C. Michael Gibson discuss the PANTHER trial, which compared P2Y12 inhibitor monotherapy with aspririn monotherapy in patients with coronary artery disease.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Radial vs. Femoral Access for PCI: Meta-Analysis
9:44
9:44
Play later
Play later
Lists
Like
Liked
9:44
Giuseppe Gargiulo and C. Michael Gibson discuss whether the choice of radial or femoral artery access impacts the risk of mortality and major bleeding for patients undergoing coronary procedures.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 181: ACT Outpatient and Inpatient Trials
5:39
5:39
Play later
Play later
Lists
Like
Liked
5:39
Sanjit Jolly and C. Michael Gibson discuss if colchicine and rivaroxaban plus aspirin can slow disease progression in patients hospitalized with COVID-19.By TCTMD
…
continue reading
Milind Desai and C. Michael Gibson compare the results of mavacamten for severe obstructive hypertropic cardiomyopathy with the typical treatments of surgical septal myectomy or alcohol ablation.By TCTMD
…
continue reading
Justin Ezekowitz and C. Michael Gibson look at a sodium-reducing dietary intervention and its effects on patients with HF.By TCTMD
…
continue reading
Shamir Mehta and C. Michael Gibson discuss how complete revascularization affects angina-related quality of life in patients with STEMI.By TCTMD
…
continue reading
Tijn Jansen, Suzette Elias-Smale, and C. Michael Gibson discuss whether diltiazem improves coronary vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease.By TCTMD
…
continue reading
Mark Loeb and C. Michael Gibson discuss whether the influenza vaccine can reduce adverse vascular events among patients with HF.By TCTMD
…
continue reading
Gregory Lewis and C. Michael Gibson discuss how omecamtiv mecarbil affects exercise tolerance in patients with chronic HFrEF.By TCTMD
…
continue reading
Javed Butler and C. Michael Gibson discuss using patiromer to manage hyperkalemia in patients with HFrEF who are taking RAAS inhibitors.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 173: MAVA-LTE: The EXPLORER-LTE Cohort
8:13
8:13
Play later
Play later
Lists
Like
Liked
8:13
Florian Rader and C. Michael Gibson look at cumulative outcomes for patients with obstructive hypertrophic cardiomyopathy treated with mavacamten.By TCTMD
…
continue reading
Manesh Patel and C. Michael Gibson discuss the results of a phase II trial comparing the safety profiles of asundexian versus apixaban in patients with atrial fibrillation.By TCTMD
…
continue reading
Daniel Sessler and C. Michael Gibson compare myocardial injury rates following mild hypothermia versus aggressive warming during noncardiac surgery.By TCTMD
…
continue reading
Duk-Woo Park and C. Michael Gibson discuss edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after TAVI.By TCTMD
…
continue reading
Bon-Kwon Koo and C. Michael Gibson compare the efficacy of FFR-guided and IV ultrasound-guided PCI for coronary artery stenosis.By TCTMD
…
continue reading
Marie-Sophie de Koning and C. Michael Gibson discuss whether the use of sodium thiosulfate after STEMI helps preserve cardiac function.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 167: The Spyral HTN-ON MED Pilot Study
5:00
5:00
Play later
Play later
Lists
Like
Liked
5:00
Felix Mahfoud and C. Michael Gibson examine the efficacy of renal denervation for long-term BP reduction in patients taking antihypertensive medication.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 166: Chronic Kidney Disease In CANTOS
7:23
7:23
Play later
Play later
Lists
Like
Liked
7:23
Paul Ridker and C. Michael Gibson discuss a secondary analysis from CANTOS looking at residual inflammatory and cholesterol risks based on chronic kidney disease status.By TCTMD
…
continue reading
Michael Mack and C. Michael Gibson discuss a novel method for extracting antithrombotics from the blood during CABG.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 164: The LOOP Study for AF Screening
16:31
16:31
Play later
Play later
Lists
Like
Liked
16:31
C. Michael Gibson and Jesper Hastrup Svendsen discuss the use of implantable loop recorders to prevent stroke in AF.By TCTMD
…
continue reading
C. Michael Gibson and George Dangas discuss edoxaban vs vitamin K antagonists after TAVI in patients with atrial fibrillation.By TCTMD
…
continue reading
Episode 162: The FIGARO-DKD Trial by TCTMDBy TCTMD
…
continue reading
C. Michael Gibson and Dhanunjaya Lakkireddy discuss device success and thrombus risk in Amulet versus Watchman for LAA closure.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 160: Shock Classification Gets an Update
4:06
4:06
Play later
Play later
Lists
Like
Liked
4:06
C. Michael Gibson and Timothy Henry discuss key updates to the SCAI SHOCK classifications.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 159: MICHELLE: Rivaroxaban in COVID-19
7:37
7:37
Play later
Play later
Lists
Like
Liked
7:37
C. Michael Gibson and Renato Lopes discuss extended DOAC prophylaxis in medically ill, hospitalized patients with COVID-19.By TCTMD
…
continue reading
C. Michael Gibson and Nicholas Curzen discuss whether routine pressure-wire assessment influences the use of coronary angiography for diagnosing chest pain.By TCTMD
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 157: PARTNER 3: Two-Year Economic Outcomes
4:33
4:33
Play later
Play later
Lists
Like
Liked
4:33
C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial.By TCTMD
…
continue reading
C. Michael Gibson and Ole Fröbert discuss the potential for influenza vaccination in post-MI patients.By TCTMD
…
continue reading